JPH11253177A5 - - Google Patents

Info

Publication number
JPH11253177A5
JPH11253177A5 JP1998320169A JP32016998A JPH11253177A5 JP H11253177 A5 JPH11253177 A5 JP H11253177A5 JP 1998320169 A JP1998320169 A JP 1998320169A JP 32016998 A JP32016998 A JP 32016998A JP H11253177 A5 JPH11253177 A5 JP H11253177A5
Authority
JP
Japan
Prior art keywords
recombinant polynucleotide
sequence
cell
promoter sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998320169A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11253177A (ja
JP4070331B2 (ja
Filing date
Publication date
Priority claimed from US08/851,843 external-priority patent/US6093809A/en
Priority claimed from US08/854,050 external-priority patent/US6261836B1/en
Priority claimed from US08/912,951 external-priority patent/US6475789B1/en
Application filed filed Critical
Publication of JPH11253177A publication Critical patent/JPH11253177A/ja
Publication of JPH11253177A5 publication Critical patent/JPH11253177A5/ja
Application granted granted Critical
Publication of JP4070331B2 publication Critical patent/JP4070331B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP32016998A 1996-10-01 1998-10-15 ヒトテロメラーゼ触媒性サブユニットプロモーター Expired - Lifetime JP4070331B2 (ja)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US72464396A 1996-10-01 1996-10-01
US08/724,643 1996-10-01
US84441997A 1997-04-18 1997-04-18
US08/844,419 1997-04-18
US84601797A 1997-04-25 1997-04-25
US08/846,017 1997-04-25
US08/851,843 US6093809A (en) 1996-10-01 1997-05-06 Telomerase
US08/851,843 1997-05-06
US08/854,050 1997-05-09
US08/854,050 US6261836B1 (en) 1996-10-01 1997-05-09 Telomerase
US91550397A 1997-08-14 1997-08-14
US91131297A 1997-08-14 1997-08-14
US08/912,951 US6475789B1 (en) 1996-10-01 1997-08-14 Human telomerase catalytic subunit: diagnostic and therapeutic methods
US08/915,503 1997-08-14
US08/912,951 1997-08-14
US08/911,312 1997-08-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP28618297A Division JP3869092B2 (ja) 1996-10-01 1997-10-01 ヒトテロメラーゼ触媒性サブユニット

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP11042410A Division JPH11313689A (ja) 1996-10-01 1999-02-19 ヒトテロメラ―ゼ触媒性サブユニット

Publications (3)

Publication Number Publication Date
JPH11253177A JPH11253177A (ja) 1999-09-21
JPH11253177A5 true JPH11253177A5 (enExample) 2005-06-23
JP4070331B2 JP4070331B2 (ja) 2008-04-02

Family

ID=27575511

Family Applications (7)

Application Number Title Priority Date Filing Date
JP51690998A Pending JP2001510985A (ja) 1996-10-01 1997-10-01 ヒトテロメラーゼ触媒性サブユニット
JP28618297A Expired - Lifetime JP3869092B2 (ja) 1996-10-01 1997-10-01 ヒトテロメラーゼ触媒性サブユニット
JP51680298A Pending JP2001523947A (ja) 1996-10-01 1997-10-01 テロメラーゼ逆転写酵素
JP32016998A Expired - Lifetime JP4070331B2 (ja) 1996-10-01 1998-10-15 ヒトテロメラーゼ触媒性サブユニットプロモーター
JP11042410A Pending JPH11313689A (ja) 1996-10-01 1999-02-19 ヒトテロメラ―ゼ触媒性サブユニット
JP2000227474A Withdrawn JP2001081042A (ja) 1996-10-01 2000-07-27 ヒトテロメラーゼ触媒性サブユニット
JP2008194208A Expired - Lifetime JP4852576B2 (ja) 1996-10-01 2008-07-28 ヒトテロメラーゼ触媒性サブユニット

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP51690998A Pending JP2001510985A (ja) 1996-10-01 1997-10-01 ヒトテロメラーゼ触媒性サブユニット
JP28618297A Expired - Lifetime JP3869092B2 (ja) 1996-10-01 1997-10-01 ヒトテロメラーゼ触媒性サブユニット
JP51680298A Pending JP2001523947A (ja) 1996-10-01 1997-10-01 テロメラーゼ逆転写酵素

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP11042410A Pending JPH11313689A (ja) 1996-10-01 1999-02-19 ヒトテロメラ―ゼ触媒性サブユニット
JP2000227474A Withdrawn JP2001081042A (ja) 1996-10-01 2000-07-27 ヒトテロメラーゼ触媒性サブユニット
JP2008194208A Expired - Lifetime JP4852576B2 (ja) 1996-10-01 2008-07-28 ヒトテロメラーゼ触媒性サブユニット

Country Status (20)

Country Link
US (4) US6166178A (enExample)
EP (6) EP0954585B1 (enExample)
JP (7) JP2001510985A (enExample)
KR (2) KR100530483B1 (enExample)
CN (3) CN1291231B (enExample)
AT (3) ATE552341T1 (enExample)
AU (2) AU4803697A (enExample)
BR (3) BR9712254A (enExample)
CA (3) CA2645721C (enExample)
DE (5) DE69739497D1 (enExample)
EA (2) EA199900349A1 (enExample)
ES (1) ES2205132T5 (enExample)
FI (1) FI990655A7 (enExample)
FR (1) FR2757177A1 (enExample)
GB (2) GB2317891C (enExample)
IL (2) IL129222A0 (enExample)
NO (2) NO319982B1 (enExample)
NZ (1) NZ334709A (enExample)
SG (1) SG94355A1 (enExample)
WO (2) WO1998014593A2 (enExample)

Families Citing this family (178)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958680A (en) 1994-07-07 1999-09-28 Geron Corporation Mammalian telomerase
US6517834B1 (en) * 1995-08-04 2003-02-11 Geron Corporation Purified telomerase
US6545133B1 (en) 1995-08-04 2003-04-08 Geron Corporation Methods for purifying telomerase
US6582904B2 (en) 1995-11-16 2003-06-24 Michael W. Dahm Method of quantifying tumour cells in a body fluid and a suitable test kit
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
US6607898B1 (en) 1996-03-26 2003-08-19 Oncomedx, Inc. Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
US6475789B1 (en) 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US6444650B1 (en) * 1996-10-01 2002-09-03 Geron Corporation Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
US6093809A (en) 1996-10-01 2000-07-25 University Technology Corporation Telomerase
US6261836B1 (en) 1996-10-01 2001-07-17 Geron Corporation Telomerase
US6808880B2 (en) 1996-10-01 2004-10-26 Geron Corporation Method for detecting polynucleotides encoding telomerase
DE69739497D1 (de) * 1996-10-01 2009-08-27 Geron Corp Menschlische Telomerase katalytische Untereinheit
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
US6777203B1 (en) * 1997-11-19 2004-08-17 Geron Corporation Telomerase promoter driving expression of therapeutic gene sequences
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US7390891B1 (en) * 1996-11-15 2008-06-24 Amgen Inc. Polynucleotides encoding a telomerase component TP2
WO1998023759A2 (en) * 1996-11-26 1998-06-04 Baylor College Of Medicine Identification of inhibitors that prevent access of telomerase to chromosomal terminus
WO1998037181A2 (en) * 1997-02-20 1998-08-27 Whitehead Institute For Biomedical Research Telomerase catalytic subunit gene and encoded protein
US7622549B2 (en) 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US7413864B2 (en) 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
US20050013825A1 (en) * 1997-04-18 2005-01-20 Geron Corporation Vaccine containing the catalytic subunit of telomerase for treating cancer
JP2002508662A (ja) * 1997-06-20 2002-03-19 バイエル・アクチエンゲゼルシヤフト ヒトテロメラーゼの触媒サブユニット並びにその診断的及び治療的使用
EP1571215A3 (en) * 1997-07-01 2007-10-31 Cambia Biosystems LLC Vertebrate telomerase genes and proteins and uses thereof
AU748442B2 (en) 1997-07-01 2002-06-06 Cambia Vertebrate telomerase genes and proteins and uses thereof
US7378244B2 (en) * 1997-10-01 2008-05-27 Geron Corporation Telomerase promoters sequences for screening telomerase modulators
AU1606999A (en) * 1997-11-26 1999-06-15 Albert Einstein College Of Medicine Of Yeshiva University Mouse telomerase reverse transcriptase
DE19757984A1 (de) * 1997-12-24 1999-07-01 Bayer Ag Regulatorische DNA-Sequenzen aus der 5'-Region vom Gen der humanen katalytischen Telomerase-Untereinheit udn deren diagnostische und therapeutische Verwendung
DE19804372A1 (de) * 1998-02-04 1999-08-05 Michael W Dr Dr Dahm Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits
US6639057B1 (en) 1998-03-26 2003-10-28 Kyowa Hakko Kogyo Co., Ltd. Monoclonal antibody against human telomerase catalytic subunit
US6337200B1 (en) * 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
JP2002509716A (ja) 1998-03-31 2002-04-02 ユニバーシティ テクノロジー コーポレイション テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
US20030105315A1 (en) * 1998-04-09 2003-06-05 Metagen Pharmaceuticals Gmbh Human nucleic acid sequences from ovarian tumor tissue
US7030211B1 (en) 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
US6900049B2 (en) 1998-09-10 2005-05-31 Cell Genesys, Inc. Adenovirus vectors containing cell status-specific response elements and methods of use thereof
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
DE69934426T2 (de) 1998-10-29 2007-10-04 Whitehead Institute For Biomedical Research, Cambridge KREBSIMMUNTHERAPIE UND KREBSDIAGNOSE UNTER VERWENDUNG UNIVERSELLER TUMORASSOZIIERTER ANTIGENE EINSCHLIESSLICH hTERT
GB9900298D0 (en) * 1999-01-07 1999-02-24 Medical Res Council Optical sorting method
WO2000043501A2 (de) * 1999-01-22 2000-07-27 Humboldt-Universität Zu Berlin Universitätsklinikum Charite GEGEN DIE KATALYTISCHE UNTEREINHEIT DER HUMANEN TELOMERASE (hTERT) GERICHTETE RIBOZYME
AU761567B2 (en) * 1999-02-04 2003-06-05 Geron Corporation Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer
US7960540B2 (en) 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
ES2296615T3 (es) 1999-04-08 2008-05-01 Antisoma Research Limited Actividad antiproliferativa de oligonucleotidos ricos en g y procedimiento de uso de los mismos para su union a la nucleolina.
US8114850B2 (en) 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
CA2368967A1 (en) * 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine
US6358739B1 (en) * 1999-04-12 2002-03-19 Modex Therapeutiques, S.A. Transiently immortalized cells
DE19916929A1 (de) 1999-04-15 2000-10-19 Bayer Ag Ein automatisierbarer Schnelltest zum Nachweis von Krebserkrankungen auf der Basis von Telomerase(hTC) mRNA mit spezifischen Primern und Sonden
US6995145B1 (en) 1999-06-04 2006-02-07 Au Jessie L-S Methods and compositions for modulating drug activity through telomere damage
US20050255596A1 (en) * 1999-09-07 2005-11-17 West Michael D Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer
AU767646B2 (en) 1999-09-10 2003-11-20 Geron Corporation Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US6399384B1 (en) 1999-09-17 2002-06-04 Reneuron Limited Conditional immortalization of cells
WO2001036971A1 (en) * 1999-11-16 2001-05-25 Kyowa Hakko Kogyo Co., Ltd. Method of searching for substance inhibiting binding between telomerase subunits
US7414170B2 (en) 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
GB9927353D0 (en) * 1999-11-19 2000-01-19 Cantab Pharma Res Virus preparation and use
US7074983B2 (en) 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
US6664046B1 (en) * 1999-12-16 2003-12-16 Roche Molecular Systems, Inc. Quantitation of hTERT mRNA expression
KR20010096991A (ko) * 2000-04-19 2001-11-08 임정빈 텔로머레이즈의 프로모터에 특정하게 결합하는더블유티이1 절편, 그 유전자, 발현벡터 및 그것을 이용한세포성장 억제 방법
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
IT1318504B1 (it) * 2000-05-08 2003-08-27 Talent Srl Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.
US6331399B1 (en) 2000-05-16 2001-12-18 Isis Pharmaceuticals, Inc. Antisense inhibition of tert expression
US6492171B2 (en) * 2000-05-16 2002-12-10 Isis Pharmaceuticals, Inc. Antisense modulation of TERT expression
US7250294B2 (en) 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
EP1158055A1 (fr) 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Méthode pour le diagnostic de cancers
US7078491B1 (en) 2000-09-21 2006-07-18 Amgen Inc. Selective binding agents of telomerase
WO2002042468A2 (en) 2000-11-27 2002-05-30 Geron Corporation Glycosyltransferase vectors for treating cancer
US6576464B2 (en) 2000-11-27 2003-06-10 Geron Corporation Methods for providing differentiated stem cells
AU2002226076A1 (en) * 2000-12-14 2002-06-24 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Telomerase immortalized human liver cell lines
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
AU2002232858B2 (en) 2000-12-22 2007-01-11 Sab, Llc Methods for cloning mammals using reprogrammed donor chromatin or donor cells
US6906237B2 (en) * 2001-02-27 2005-06-14 G. Scott Herron Vivo assay for anti angiogenic compounds
US20040063922A1 (en) * 2001-04-17 2004-04-01 Conrad Charles A. Methods and compositions for catalytic DNA exchange in a sequence specific manner
US7262174B2 (en) * 2001-05-09 2007-08-28 Geron Corporation Treatment for wounds
GB0112342D0 (en) * 2001-05-21 2001-07-11 Norsk Hydro As Polypeptides
US7291499B2 (en) 2001-07-16 2007-11-06 Fuyuki Ishikawa Transformed cell, method of screening anti-aging agent and anti-aging agent
AU2002327433A1 (en) * 2001-08-10 2003-02-24 Cornell Research Foundation, Inc. Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells
AUPR769701A0 (en) * 2001-09-14 2001-10-11 Li, He Telomerase inhibitory peptides and uses thereof
AU2002350495B2 (en) * 2001-10-18 2009-05-07 Heart Biosystems Gmbh Transient immortalization
CA2466732A1 (en) * 2001-10-22 2003-05-01 University Of Rochester Telomerase interference
US20050084959A1 (en) * 2001-10-31 2005-04-21 Hirofumi Hamada Immortalized mesenchymal cells and utilization thereof
CN1630716A (zh) 2001-12-07 2005-06-22 杰龙公司 人胚胎干细胞衍生的造血细胞
CN101240262A (zh) * 2001-12-07 2008-08-13 杰龙公司 源自人胚胎干细胞的胰岛细胞
DE10163130B4 (de) * 2001-12-20 2009-05-14 Cyto Tools Gmbh Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen
JPWO2003054545A1 (ja) * 2001-12-21 2005-04-28 清史 村上 抗テロメラーゼ抗体の検出方法
GB0200929D0 (en) * 2002-01-16 2002-03-06 Univ Glasgow Tissue rejection
ATE548461T1 (de) * 2002-01-18 2012-03-15 Morphotek Inc Verfahren zur erzeugung manipulierter zellen zur locus-spezifischen genregulation und analyse
US20030175961A1 (en) * 2002-02-26 2003-09-18 Herron G. Scott Immortal micorvascular endothelial cells and uses thereof
US20050106729A1 (en) * 2002-05-03 2005-05-19 Mark Irvin Rosenblatt Gene transfer methods and compositions
MXPA04011731A (es) * 2002-05-28 2005-02-14 Univ Minnesota Polipetidos cris como anticonceptivos e inhibidores de la capacitacion de espermatozoides.
US7294708B2 (en) * 2002-05-31 2007-11-13 Beijing Institute Of Biotechnology Telomerase reverse transcriptase fragments and uses thereof
AU2003267967B2 (en) * 2002-06-18 2008-11-20 Zymogenetics, Inc. Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
MXPA05004870A (es) 2002-11-08 2005-11-04 Hematech Llc Ungulados transgenicos que tienen actividad reducida de la proteina prion y sus usos.
US7166692B2 (en) 2003-03-04 2007-01-23 Canbrex Bio Science Walkersville, Inc. Intracellular delivery of small molecules, proteins, and nucleic acids
US8771982B2 (en) * 2003-04-30 2014-07-08 Duke University Chimeric molecule and nucleic acid encoding same
TR201903587T4 (tr) 2003-06-23 2019-04-22 Telomerase Activation Sciences Inc Telomeraz aktivitesinin artırılması için bileşimler.
EP1664098A1 (en) * 2003-09-12 2006-06-07 Reneuron Limited Immortalisation of mammalian cells and therapeutic applications of said cells
EP1522858A1 (en) * 2003-10-10 2005-04-13 Jean-Christophe Roegel Methods for selecting compounds using antibodies with activity as agonist, antagonist or allosteric modulators
US7473418B2 (en) 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
NZ550106A (en) 2004-04-22 2009-06-26 Kyowa Hakko Kirin Co Ltd Transgenic animals and uses thereof
JP4814875B2 (ja) 2004-05-11 2011-11-16 アキシオジェネシス エージー ｉｎｖｉｔｒｏ分化細胞に基づく薬物発見のための検定
WO2006031313A2 (en) * 2004-08-05 2006-03-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for cell activation
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
JP2006242618A (ja) * 2005-03-01 2006-09-14 Univ Of Tokyo 組織ｆｉｓｈ法によるテロメア量を指標とした癌の診断
JP4635196B2 (ja) * 2005-03-04 2011-02-16 国立大学法人広島大学 遺伝子導入細胞、及びそれを用いたテロメラーゼ誘導物質の検出方法
CA2601187A1 (en) * 2005-03-09 2006-09-14 Board Of Regents, The University Of Texas System Novel htmc promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
JP2008543277A (ja) * 2005-05-11 2008-12-04 ジェネティック テクノロジーズ リミテッド 胎児細胞を富化する方法
EP1748067A1 (en) * 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
PL1969118T5 (pl) 2005-12-21 2015-06-30 Univ Catholique Louvain Wyizolowane komórki macierzyste wątroby
WO2007149182A2 (en) 2006-06-19 2007-12-27 Geron Corporation Differentiation and enrichment of islet-like cells from human pluripotent stem cells
WO2008002285A1 (en) * 2006-06-26 2008-01-03 Science Applications International Corporation Igy antibodies to human telomerase reverse transcriptase
US20080131442A1 (en) * 2006-06-26 2008-06-05 Science Applications International Corporation IgY antibodies to human telomerase reverse transcriptase
DK2049559T3 (da) 2006-07-28 2013-03-25 Univ Pennsylvania Forbedrede HPV vacciner
AU2013203229C1 (en) * 2006-07-28 2015-10-29 The Trustees Of The University Of Pennsylvania Improved vaccines and methods for using the same
EP2076531B1 (en) 2006-10-12 2011-11-23 Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
SI3255061T1 (sl) 2006-11-03 2021-09-30 The Board Of Trustees Of The Leland Stanford Junior University Selektivno imunsko osiromašenje niše endogenih matičnih celic za vsaditev
EP1994942A1 (en) * 2007-05-25 2008-11-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising telomerase, and uses thereof
AU2009205429A1 (en) 2008-01-14 2009-07-23 Conventus Orthopaedics Inc. Apparatus and methods for fracture repair
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
CA2795268A1 (en) 2009-04-21 2010-10-28 Genetic Technologies Limited Methods for obtaining fetal genetic material
PH12011502641A1 (en) * 2009-07-09 2012-11-12 Janssen Biotech Inc Cardiac tissue-derived cells
US20110178520A1 (en) 2010-01-15 2011-07-21 Kyle Taylor Rotary-rigid orthopaedic rod
US8961518B2 (en) 2010-01-20 2015-02-24 Conventus Orthopaedics, Inc. Apparatus and methods for bone access and cavity preparation
CN108383894A (zh) 2010-02-16 2018-08-10 阿尔特公司 多肽及其应用
WO2011106671A1 (en) * 2010-02-26 2011-09-01 Geron Corporation Assay for telomerase activity
AU2011224529C1 (en) 2010-03-08 2017-01-19 Conventus Orthopaedics, Inc. Apparatus and methods for securing a bone implant
JP5926240B2 (ja) 2010-04-08 2016-05-25 ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｃｏｕｒｔ ｏｆ ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ ｏｆ Ｅｄｉｎｂｕｒｇｈ 軟骨形成性始原細胞、細胞の派生のためのプロトコールおよびその使用
JPWO2012026309A1 (ja) * 2010-08-23 2013-10-28 公立大学法人横浜市立大学 抗ｐａｄ４抗体医薬の創成
CN102093980B (zh) * 2010-12-10 2013-04-17 梁伟国 永生化人椎间盘髓核细胞体系的制备方法
US8420617B2 (en) * 2011-03-11 2013-04-16 Biocell Laboratories Multiantivirus compound, composition and method for treatment of virus diseases
CN102676518B (zh) * 2012-02-27 2013-09-18 华侨大学 一种新型抗肿瘤amiRNA序列及其应用
EP2639299A1 (en) 2012-03-16 2013-09-18 Invectys Universal cancer peptides derived from telomerase
CN104661672B (zh) * 2012-05-11 2017-03-08 珍白斯凯尔有限公司 用于预防或治疗败血症的组合物
ES2691070T3 (es) * 2012-05-11 2018-11-23 Kael-Gemvax Co.,Ltd Péptidos antiinflamatorios y composición que comprende los mismos
CA2877933A1 (en) * 2012-06-27 2014-01-03 Yuri Bushkin Rapid assays for t-cell activation by rna measurements using flow cytometry
US20150125438A1 (en) * 2012-07-20 2015-05-07 Sang Jae Kim Anti-Inflammatory Peptides and Composition Comprising the Same
JP6352923B2 (ja) * 2012-09-19 2018-07-04 ジェムバックス アンド カエル カンパニー，リミティド 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
US9631184B2 (en) * 2012-09-19 2017-04-25 Gemvax & Kael Co., Ltd. Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
KR102038487B1 (ko) 2012-09-19 2019-10-30 주식회사 젬백스앤카엘 텔로머라제 펩티드를 포함하는 항균 또는 항진균용 조성물
KR102166542B1 (ko) 2012-09-28 2020-10-16 주식회사 젬백스앤카엘 줄기세포 검출을 위한 텔로머라제 유래 펩티드 및 조영물질의 컨쥬게이트 및 이를 포함하는 조영제
KR102106756B1 (ko) 2012-12-13 2020-05-06 주식회사 젬백스앤카엘 자외선에 의한 피부 손상 예방 또는 치료용 조성물
KR102093093B1 (ko) 2012-12-13 2020-03-25 주식회사 젬백스앤카엘 피부 노화 개선용 조성물
SI2959005T1 (sl) 2013-02-22 2022-01-31 The Board Of Trustees Of The Leland Stanford Junior University Medicinska uporaba v zvezi z ekstenzijo telomera
US9931387B2 (en) 2013-03-28 2018-04-03 Invectys Cancer vaccine for cats
WO2014154905A1 (en) 2013-03-28 2014-10-02 Invectys A cancer vaccine for dogs
KR102523912B1 (ko) 2013-06-11 2023-04-21 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 SC-β 세포 및 조성물 그리고 그 생성 방법
EA035485B1 (ru) 2013-10-28 2020-06-24 Инвектис Электроперенос генов в клетки кожи
KR102252756B1 (ko) 2013-10-28 2021-05-17 잉벡띠스 텔로머라제 암호화 dna 백신
EP2871235A1 (en) * 2013-11-07 2015-05-13 Centre National de la Recherche Scientifique (CNRS) New methods to produce active hTERT
WO2015089357A2 (en) 2013-12-12 2015-06-18 Conventus Orthopaedics, Inc. Tissue displacement tools and methods
KR102166549B1 (ko) 2014-01-10 2020-10-16 주식회사 젬백스앤카엘 혈뇌장벽 투과성 펩티드 및 이를 포함하는 컨쥬게이트
EP3656869B2 (en) 2014-08-26 2025-04-09 The Board of Trustees of the Leland Stanford Junior University Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
WO2017079419A1 (en) 2015-11-05 2017-05-11 The Regents Of The University Of California Cells labelled with lipid conjugates and methods of use thereof
WO2017125844A1 (en) 2016-01-19 2017-07-27 Pfizer Inc. Cancer vaccines
BR112019015342A2 (pt) 2017-01-30 2020-03-10 The Board Of Trustees Of The Leland Stanford Junior University Regime de condicionamento não genotóxico para o transplante de células-tronco
US10631881B2 (en) 2017-03-09 2020-04-28 Flower Orthopedics Corporation Plating depth gauge and countersink instrument
US11351246B2 (en) 2017-05-09 2022-06-07 Invectys SAS Recombinant measles vaccine expressing hTERT
WO2019010252A2 (en) 2017-07-04 2019-01-10 Conventus Orthopaedics, Inc. Apparatus and methods for treatment of a bone
US11786557B2 (en) 2017-10-02 2023-10-17 Fred Hutchinson Cancer Center Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cells
CN108715863B (zh) * 2018-05-30 2020-09-11 吉林大学 一种肿瘤靶向性载体pcTERT及其构建方法及其应用
CN110827920B (zh) * 2018-08-14 2022-11-22 武汉华大医学检验所有限公司 测序数据分析方法和设备及高通量测序方法
EP3847274A4 (en) * 2018-09-05 2022-06-08 Readcoor, LLC Methods and systems for therapeutic agent analysis
CN112654244B (zh) * 2018-09-06 2023-07-25 德克萨斯大学系统董事会 端粒酶全酶复合体及其使用方法
WO2020076976A1 (en) 2018-10-10 2020-04-16 Readcoor, Inc. Three-dimensional spatial molecular indexing
CN109545039A (zh) * 2019-01-15 2019-03-29 苏州大学 一种核孔复合体结构模型教具及其使用方法
US20220364059A1 (en) 2019-07-05 2022-11-17 Case Western Reserve University Priming media and methods for stem cell culture and therapy
JP2021151979A (ja) * 2020-03-24 2021-09-30 均 石井 再生医療薬
US20220049303A1 (en) 2020-08-17 2022-02-17 Readcoor, Llc Methods and systems for spatial mapping of genetic variants
CN116870195A (zh) * 2020-09-22 2023-10-13 浙江愈方生物科技有限公司 一种灭活性端粒酶、具有其的腺病毒和人造mRNA及应用
JP2022119144A (ja) * 2021-02-03 2022-08-16 均 石井 パーキンソン病治療薬
JP2022151412A (ja) * 2021-03-23 2022-10-07 均 石井 脳卒中治療薬
CN113355303B (zh) * 2021-06-07 2023-06-16 中元汇吉生物技术股份有限公司 一种m-mlv逆转录酶突变体及其应用
EP4463151A4 (en) 2022-01-19 2025-10-01 Univ Northwestern Agents Targeting Telomerase Reverse Transcriptase (TERT) to Treat Cancer and Sensitize Cancer Cells to Genotoxic Therapy
CN114920802B (zh) * 2022-05-16 2023-05-23 中国地质大学（武汉） 调节端粒酶限速蛋白运动的多肽探针及其复合物和方法
CN116364195B (zh) * 2023-05-10 2023-10-13 浙大城市学院 一种基于预训练模型的微生物遗传序列表型预测方法

Family Cites Families (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US912629A (en) 1908-08-29 1909-02-16 Conrad L Stueber Foundation-top for pipe-carriers.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4254082A (en) 1978-06-12 1981-03-03 Miles Laboratories, Inc. Specific binding-adsorbent assay test means
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
JPS57502090A (enExample) 1980-07-18 1982-11-25
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US5055556A (en) 1981-10-06 1991-10-08 The Board Of Trustees Of The Leland Stanford Jr. Univ. Fluorescent conjugates for analysis of molecules and cells
JPS58215453A (ja) 1982-06-09 1983-12-14 Toray Silicone Co Ltd 室温硬化後塗装可能なオルガノポリシロキサン組成物
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
FR2542494B1 (fr) 1983-03-08 1985-08-16 Sevylor International Combinaison protectrice, utilisable notamment en atmosphere irradiee
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5272065A (en) 1983-10-20 1993-12-21 Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
GB8612087D0 (en) 1986-05-19 1986-06-25 Ici Plc Hybridisation probes
US5001225A (en) 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
US4889806A (en) 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
US5017478A (en) 1987-07-16 1991-05-21 Berlex Laboratories, Inc. Transfected cells containing plasmids having genes oriented in opposing directions and methods of using
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5093245A (en) 1988-01-26 1992-03-03 Applied Biosystems Labeling by simultaneous ligation and restriction
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5075227A (en) * 1989-03-07 1991-12-24 Zymogenetics, Inc. Directional cloning
JPH02307059A (ja) 1989-05-23 1990-12-20 Seiko Instr Inc 反応容器
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
AU647741B2 (en) 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
DE69027683T2 (de) 1989-12-01 1997-02-13 Pharming Bv Herstellung rekombinanter polypeptide durch rinder und transgene methoden
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
EP1375666A3 (en) 1989-12-22 2007-09-26 Applied Research Systems ARS Holding N.V. Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
JPH04505546A (ja) 1990-02-09 1992-09-24 アスラブ　ソシエテ　アノニム 写真平版マイクロ製造法を用いて製造した放射場静電マイクロモーター及び前記マイクロモーターの製造方法
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
SE468913B (sv) 1990-05-16 1993-04-05 Igesto Ab Saekerhetskrok
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
KR100198659B1 (ko) 1996-05-16 1999-06-15 구본준 메모리 셀, 메모리 장치 및 그의 제조 방법
JP2904583B2 (ja) 1991-10-11 1999-06-14 プロメガ・コーポレーション 真核無細胞抽出物中での転写と翻訳の共役
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
PT101031B (pt) 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
EP0642589A4 (en) 1992-05-11 1997-05-21 Ribozyme Pharm Inc METHOD AND REAGENT TO INHIBIT VIRAL REPLICATION.
US5629154A (en) 1993-11-12 1997-05-13 Geron Corporation Telomerase activity assays
US5639613A (en) 1992-05-13 1997-06-17 Board Of Regents, University Of Texas System Methods for cancer diagnosis and prognosis
US5489508A (en) 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5645986A (en) 1992-05-13 1997-07-08 Board Of Reagents, The University Of Texas System Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5648215A (en) 1992-05-13 1997-07-15 Board Of Regents, The University Of Texas System Telomerase diagnostic methods
EP1251170A3 (en) 1992-07-17 2002-10-30 Ribozyme Pharmaceuticals, Inc. Method and reagent for treatment of NF-kappaB dependent animal diseases
US6107062A (en) 1992-07-30 2000-08-22 Inpax, Inc. Antisense viruses and antisense-ribozyme viruses
GB2273932A (en) 1992-11-24 1994-07-06 Stiefel Laboratories Stable oligonucleotides
US5674703A (en) 1992-12-02 1997-10-07 Woo; Savio L. C. Episomal vector systems and related methods
EP1024198A3 (en) 1992-12-03 2002-05-29 Genzyme Corporation Pseudo-adenoviral vectors for the gene therapy of haemophiliae
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
JPH08508636A (ja) 1993-01-27 1996-09-17 オンコール インコーポレーテッド 核酸配列の増幅
US5919676A (en) 1993-06-24 1999-07-06 Advec, Inc. Adenoviral vector system comprising Cre-loxP recombination
US6140087A (en) 1993-06-24 2000-10-31 Advec, Inc. Adenovirus vectors for gene therapy
US6120764A (en) 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
WO1995013382A1 (en) * 1993-11-12 1995-05-18 Geron Corporation Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5583016A (en) 1994-07-07 1996-12-10 Geron Corporation Mammalian telomerase
DK0778842T3 (da) 1994-07-07 2006-03-20 Geron Corp Mammal telomerase
US5597697A (en) 1994-09-30 1997-01-28 Diamond; Paul Screening assay for inhibitors and activators of RNA and DNA-dependent nucleic acid polymerases
US5698686A (en) 1994-10-20 1997-12-16 Arch Development Corporation Yeast telomerase compositions
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
EP0799315A2 (en) 1994-12-19 1997-10-08 Cold Spring Harbor Laboratory Telomerase protein component
US5741677A (en) 1995-06-07 1998-04-21 Geron Corporation Methods for measuring telomere length
US5722998A (en) 1995-06-07 1998-03-03 Intermedics, Inc. Apparatus and method for the control of an implantable medical device
AU701903B2 (en) 1995-06-07 1999-02-11 Cold Spring Harbor Laboratory Essential oligonucleotides of vertebrate telomerase
WO1997015687A1 (en) 1995-06-07 1997-05-01 Geron Corporation Telomerase activity assays
US6545133B1 (en) 1995-08-04 2003-04-08 Geron Corporation Methods for purifying telomerase
US6517834B1 (en) 1995-08-04 2003-02-11 Geron Corporation Purified telomerase
US5968506A (en) 1995-08-04 1999-10-19 Geron Corporation Purified telomerase
JP3372258B2 (ja) 1995-08-04 2003-01-27 インターナシヨナル・ビジネス・マシーンズ・コーポレーシヨン リソグラフィ・プロセス用のスタンプ
JPH09154575A (ja) 1995-10-04 1997-06-17 Soosei:Kk テロメラーゼ
JPH09164575A (ja) 1995-12-13 1997-06-24 Japan Steel Works Ltd:The 流れ模様を有する樹脂板の製造方法およびその装置
US6015710A (en) 1996-04-09 2000-01-18 The University Of Texas System Modulation of mammalian telomerase by peptide nucleic acids
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
US5747317A (en) 1996-07-08 1998-05-05 Tularik Inc. Human telomerase RNA interacting protein gene
US5770422A (en) 1996-07-08 1998-06-23 The Regents Of The University Of California Human telomerase
US5724021A (en) 1996-07-09 1998-03-03 Stephen C. Perrone Self-contained, programmable, time interval alarm reminder device for eyedrop medication administration and a means for affixing such to eyedrop/medication container
WO1998007838A1 (en) 1996-08-21 1998-02-26 Mitsubishi Chemical Corporation Higher animal telomerase protein and gene encoding the same
AUPO181296A0 (en) 1996-08-21 1996-09-12 Commonwealth Scientific And Industrial Research Organisation Manipulation of proanthocyanidin biosynthesis
WO1998008938A1 (fr) 1996-08-28 1998-03-05 Shonen Yoshida Proteines ayant une activite de telomerase
DE19638482A1 (de) 1996-09-20 1998-04-02 Bosch Gmbh Robert Verfahren zur Auswahl einer Sendefrequenz
US6475789B1 (en) 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US6444650B1 (en) * 1996-10-01 2002-09-03 Geron Corporation Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
US7585622B1 (en) * 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US6767719B1 (en) 1997-11-26 2004-07-27 Geron Corporation Mouse telomerase reverse transcriptase
DE69739497D1 (de) 1996-10-01 2009-08-27 Geron Corp Menschlische Telomerase katalytische Untereinheit
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
US6261836B1 (en) 1996-10-01 2001-07-17 Geron Corporation Telomerase
US6808880B2 (en) 1996-10-01 2004-10-26 Geron Corporation Method for detecting polynucleotides encoding telomerase
US6777203B1 (en) 1997-11-19 2004-08-17 Geron Corporation Telomerase promoter driving expression of therapeutic gene sequences
US6093809A (en) 1996-10-01 2000-07-25 University Technology Corporation Telomerase
US5890326A (en) 1996-11-06 1999-04-06 Hill-Rom, Inc. Head wall for a hospital room
US5919656A (en) 1996-11-15 1999-07-06 Amgen Canada Inc. Genes encoding telomerase protein 1
US7390891B1 (en) * 1996-11-15 2008-06-24 Amgen Inc. Polynucleotides encoding a telomerase component TP2
WO1998023759A2 (en) 1996-11-26 1998-06-04 Baylor College Of Medicine Identification of inhibitors that prevent access of telomerase to chromosomal terminus
WO1998037181A2 (en) * 1997-02-20 1998-08-27 Whitehead Institute For Biomedical Research Telomerase catalytic subunit gene and encoded protein
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
JP2001509681A (ja) * 1997-04-04 2001-07-24 ジェロン コーポレイション 精製されたテロメラーゼ
US6485789B1 (en) 1997-04-14 2002-11-26 3M Innovative Properties Company Fluorochemical composition containing a condensation product of a fluorochemical polyether and a poly-isocyanate to impart stain release properties to a substrate
US7413864B2 (en) 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
US7622549B2 (en) * 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US20050013825A1 (en) 1997-04-18 2005-01-20 Geron Corporation Vaccine containing the catalytic subunit of telomerase for treating cancer
US6201830B1 (en) 1997-06-11 2001-03-13 Texas Instruments Incorporated Low computation idle transmission method for DSL modems
JP2002508662A (ja) * 1997-06-20 2002-03-19 バイエル・アクチエンゲゼルシヤフト ヒトテロメラーゼの触媒サブユニット並びにその診断的及び治療的使用
AU748442B2 (en) 1997-07-01 2002-06-06 Cambia Vertebrate telomerase genes and proteins and uses thereof
US7378244B2 (en) 1997-10-01 2008-05-27 Geron Corporation Telomerase promoters sequences for screening telomerase modulators
AU1606999A (en) 1997-11-26 1999-06-15 Albert Einstein College Of Medicine Of Yeshiva University Mouse telomerase reverse transcriptase
DE19757984A1 (de) 1997-12-24 1999-07-01 Bayer Ag Regulatorische DNA-Sequenzen aus der 5'-Region vom Gen der humanen katalytischen Telomerase-Untereinheit udn deren diagnostische und therapeutische Verwendung
AU1785099A (en) 1998-01-08 1999-07-26 Chugai Seiyaku Kabushiki Kaisha Novel gene having reverse transcriptase motif
GB9801902D0 (en) 1998-01-29 1998-03-25 Cancer Res Campaign Tech A gene promoter
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
JP2002509716A (ja) 1998-03-31 2002-04-02 ユニバーシティ テクノロジー コーポレイション テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
US6069471A (en) 1998-05-14 2000-05-30 Intel Corporation Dynamic set point switching regulator
EP1085892A4 (en) 1998-06-12 2002-07-17 Sloan Kettering Inst Cancer VACCINATION STRATEGY FOR PREVENTING AND TREATING CANCERS
US7030211B1 (en) 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
AU761567B2 (en) 1999-02-04 2003-06-05 Geron Corporation Replicative virus driven by the promoter for telomerase reverse transcriptase for use in treating cancer
CA2368967A1 (en) 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine
WO2000073420A2 (en) 1999-06-02 2000-12-07 Whitehead Institute For Biomedical Research Creation of human tumorigenic cells and uses therefor
US6354941B2 (en) 1999-11-03 2002-03-12 516 Holdings Electronic system for a game of chance
JP2004527449A (ja) 2000-02-15 2004-09-09 リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア テロメラーゼ逆転写酵素を用いる癌を治療するための万能ワクチンと方法
US7262174B2 (en) 2001-05-09 2007-08-28 Geron Corporation Treatment for wounds
JP2002348474A (ja) 2001-05-23 2002-12-04 Dow Corning Toray Silicone Co Ltd ポリオルガノシロキサンマイクロエマルジョン組成物および化粧料原料
WO2003038047A2 (en) 2001-10-29 2003-05-08 Baylor College Of Medicine Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen
US7294708B2 (en) * 2002-05-31 2007-11-13 Beijing Institute Of Biotechnology Telomerase reverse transcriptase fragments and uses thereof
KR100705868B1 (ko) 2003-05-06 2007-04-10 후지 덴키 디바이스 테크놀로지 가부시키가이샤 반도체 장치 및 그 제조 방법

Similar Documents

Publication Publication Date Title
JPH11253177A5 (enExample)
Poncet et al. Rotavirus protein NSP3 (NS34) is bound to the 3'end consensus sequence of viral mRNAs in infected cells
Scadden et al. Specific cleavage of hyper‐edited dsRNAs
Rueter et al. Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine
Sakamoto et al. Control of Drosophila Sex-lethal pre-mRNA splicing by its own female-specific product
ES2543730T3 (es) Sistema mejorado de expresión de proteína
WO2000046355B1 (en) Telomerase reverse transcriptase transcriptional regulatory sequences
JP2018533375A5 (enExample)
CN106434663A (zh) CRISPR/Cas9靶向敲除人ezrin基因增强子关键区的方法及其特异性gRNA
CN110036107B (zh) TCRα归巢核酸内切酶变体
Buzdin Retroelements and formation of chimeric retrogenes
Danilovic et al. Correlations of CTLA‐4 gene polymorphisms and hepatitis C chronic infection
Sýkorová et al. The signature of the Cestrum genome suggests an evolutionary response to the loss of (TTTAGGG) n telomeres
Stazic et al. A novel strategy for exploitation of host RNase E activity by a marine cyanophage
Falk et al. Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP)
Rothe et al. Genomic organization and promoter function of the murine tumor necrosis factor receptor β gene
CN116261594A (zh) 用于核碱基编辑的锌指融合蛋白
Shors et al. Complementation of Deletion of the Vaccinia Virus E3L Gene by theEscherichia coliRNase III Gene
Arnaud et al. Analysis of the SINE S1 Pol III promoter from Brassica; impact of methylation and influence of external sequences
Macías et al. Biology of Trypanosoma cruzi retrotransposons: from an enzymatic to a structural point of view
CN110747191A (zh) 多肽、嵌合聚合酶及其应用
Lu et al. The p95 gene of Bombyx mori nuclear polyhedrosis virus: temporal expression and functional properties
KR960023056A (ko) 푸자리움 옥시스포룸으로부터의 페니실린 v 아미도하이드롤라아제 유전자
WO2025045078A1 (zh) 一种用于调控rna甲基化修饰的编辑系统及其应用
Ward et al. Cloning and analysis of the human complement factor H gene promoter